Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Benkert

Showing results (51-60 of 135) with videos related to

Pageof 14
Sort By:
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 12, 2024
Polygenic risk for Alzheimer's disease is associated with neuroaxonal damage before onset of clinical symptomsSonja M Kagerer, Swapnil Awasthi, Stephan Ripke, et al.
BMJ Open|June 25, 2026
Evolution of blood biomarkers reflective of brain tissue damage and inflammation in the perioperative course of intracerebral haemorrhage evacuation in a phase II proof-of-concept trialTim Jonas Hallenberger, Eline Willemse, Catherine Brégère, et al.
Annals of Neurology|February 16, 2022
Immunological Predictors of Dimethyl Fumarate-Induced LymphopeniaMartin Diebold, Edoardo Galli, Andreas Kopf, et al.
Neurology|May 22, 2020
Plasma neurofilament light levels are associated with risk of disability in multiple sclerosisAli Manouchehrinia, Pernilla Stridh, Mohsen Khademi, et al.
Annals of Neurology|May 10, 2018
Prodromal symptoms of multiple sclerosis in primary careGiulio Disanto, Chiara Zecca, Sharon MacLachlan, et al.
Neuroimage. Clinical|August 25, 2022
Brain atrophy measurement over a MRI scanner change in multiple sclerosisTim Sinnecker, Sabine Schädelin, Pascal Benkert, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
Concentrations of Serum Brain Injury Biomarkers Following SARS-CoV-2 Infection in Individuals with and without Long-COVID-Results from the Prospective Population-Based COVI-GAPP StudyJulia Telser, Kirsten Grossmann, Ornella C Weideli, et al.
Neurology|February 26, 2025
Comparative Performances of 4 Serum NfL Assays, pTau181, and GFAP in Patients With Amyotrophic Lateral SclerosisEtienne Mondesert, Constance Delaby, Elisa De La Cruz, et al.
Plos One|November 21, 2024
Factors associated with low health-related quality of life in persons with multiple sclerosis: A quantile-based segmentation approachStefania Iaquinto, Benjamin Victor Ineichen, Anke Salmen, et al.
Annals of Clinical and Translational Neurology|May 27, 2020
Temporal association of sNfL and gad-enhancing lesions in multiple sclerosisMattia Rosso, Cindy T Gonzalez, Brian C Healy, et al.
Pageof 14

Showing results (51-60 of 135) with videos related to

Sort By:
Pageof 14
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 12, 2024
Polygenic risk for Alzheimer's disease is associated with neuroaxonal damage before onset of clinical symptomsSonja M Kagerer, Swapnil Awasthi, Stephan Ripke, et al.
BMJ Open|June 25, 2026
Evolution of blood biomarkers reflective of brain tissue damage and inflammation in the perioperative course of intracerebral haemorrhage evacuation in a phase II proof-of-concept trialTim Jonas Hallenberger, Eline Willemse, Catherine Brégère, et al.
Annals of Neurology|February 16, 2022
Immunological Predictors of Dimethyl Fumarate-Induced LymphopeniaMartin Diebold, Edoardo Galli, Andreas Kopf, et al.
Neurology|May 22, 2020
Plasma neurofilament light levels are associated with risk of disability in multiple sclerosisAli Manouchehrinia, Pernilla Stridh, Mohsen Khademi, et al.
Annals of Neurology|May 10, 2018
Prodromal symptoms of multiple sclerosis in primary careGiulio Disanto, Chiara Zecca, Sharon MacLachlan, et al.
Neuroimage. Clinical|August 25, 2022
Brain atrophy measurement over a MRI scanner change in multiple sclerosisTim Sinnecker, Sabine Schädelin, Pascal Benkert, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
Concentrations of Serum Brain Injury Biomarkers Following SARS-CoV-2 Infection in Individuals with and without Long-COVID-Results from the Prospective Population-Based COVI-GAPP StudyJulia Telser, Kirsten Grossmann, Ornella C Weideli, et al.
Neurology|February 26, 2025
Comparative Performances of 4 Serum NfL Assays, pTau181, and GFAP in Patients With Amyotrophic Lateral SclerosisEtienne Mondesert, Constance Delaby, Elisa De La Cruz, et al.
Plos One|November 21, 2024
Factors associated with low health-related quality of life in persons with multiple sclerosis: A quantile-based segmentation approachStefania Iaquinto, Benjamin Victor Ineichen, Anke Salmen, et al.
Annals of Clinical and Translational Neurology|May 27, 2020
Temporal association of sNfL and gad-enhancing lesions in multiple sclerosisMattia Rosso, Cindy T Gonzalez, Brian C Healy, et al.
Pageof 14